CORAL GABLES, FL / ACCESSWIRE / February 1, 2019 / Marijuana stocks have taken headlines by storm over the course of the past few years as companies have pulled out all the stops to convince consumers of the myriad benefits associated with the use of cannabis. Following the recent passing of the U.S. Farm Bill, companies in the cannabis industry received the boost they needed from lawmakers to nudge consumers in the right direction, resulting in an increase in favorable public opinion. The increase of capital, in tandem with growing public approval, has resulted in the cannabis sector attracting more investors looking for potential opportunities. As we close out the month of January, Leafbuyer Technologies Inc (LBUY), The Supreme Cannabis Company Inc (SPRWF), InMed Pharmaceuticals Inc (IMLFF), and Aphria Inc (APHA) (APHA) are 4 pot stocks looking to set the pace on Friday.
Leafbuyer Technologies Inc (LBUY) is one of the leading online resources for those in the cannabis industry. The Company, through its subsidiary, LB Media Group LLC, operates an online platform for trending cannabis deals and specials and has been lauded as the most comprehensive source for ascertaining cannabis-related information. The Company's platform has been referred to as the "Priceline of pot" by cannabis experts and analysts in the industry, because of the ease of access for consumers looking to learn, find, or research anything about the cannabis market.
Leafbuyer Technologies Inc (LBUY) announced earlier this week that its quarterly sales rose 68% in the quarter ending December 31, 2018. The increase reflects the revenues booked in the quarter versus the same quarter of the previous year.
Mark Breen, Chief Operating Officer of Leafbuyer Technologies Inc (LBUY), commented, "this announcement of record-setting growth follows the Company's major industry moves, including the launch of both the Leafbuyer Wallet and Leafbuyer Loyalty, as well as the acquisition of California-based, order-ahead application Greenlight in the last quarter. Our cannabis dispensary and product customers see the exceptional value in the services we offer, and we will continue to diversify our platforms to more thoroughly serve their needs."
The Supreme Cannabis Company (SPRWF) announced earlier this week that its wholly-owned subsidiary, 7ACRES, has obtained Health Canada approval to begin cultivating approximately 30,000 sqft of additional flowering rooms at its facility in Kincardine, Ontario. This raises the total flowering room space from 90,000 sqft to 120,000 sqft and 7ACRES' annual production capacity estimate increases from approximately 13,300kg to 17,500kg. With further production efficiencies and the completion and licensing of all 25 flowering rooms, the potential capacity of the 7ACRES facility is anticipated to reach approximately 50,000kg per year.
John Fowler, President, and Founder of Supreme Cannabis, commented, "scaling our 7ACRES facility is a top priority and today's announcement is another significant step forward towards completing that goal."
InMed Pharmaceuticals Inc (IMLFF), a fully integrated, cannabinoid-based biopharmaceutical company that uses its proprietary platform to develop treatments for those with unmet medical needs, saw its shares climb 9.68% on mid-afternoon trading on Friday, with shares trading at $0.5368 per share. The Company announced earlier this month that Dr. SazzadHossain, would assume a position as a member of the Scientific Advisory Board and, contemporaneously, announced his retirement as Chief Scientific Officer.
Prior to his departure, Dr. Hossain said, "InMed's continued success in developing cannabinoids to treat serious diseases is vital to me. Unfortunately, given recent personal health concerns, I wish to modify my role to that of a scientific advisor. I look forward to continuing my involvement with the entire team at InMed."
Aphria Inc (APHA) saw impressive gains in the market on Friday, with shares up nearly 14%, trading at just under $10.00 per share. The Company today announced the completion of its first transfer of plant cuttings from four of the Company's cannabis strains to Denmark-based Schroll Medical, as part of the Company's previously announced Strategic Partnership with Schroll. The shipment was completed under permits issued by the relevant health authorities, including an export permit from Health Canada, an import permit from the Danish Medicines Agency and a phytosanitary certificate from the Canadian Food Inspection Agency.
Following the Company's announcement, Hendrik Knopp, Managing Director of Aphria Germany, said, "we are pleased to introduce the first four Aphria strains to be produced in Europe, through our strategic alliance with Schroll. This marks another important milestone for Aphria as we extend our leadership position in the European market, and it gives me the joy to be able to say today that we literally have a good thing growing in Europe."
MarijuanaStocks.com is the leading web destination for all things cannabis. Investors can find marijuana-related financial, medical, legal, and social news anytime day or night. Writers are invited to submit cannabis related articles for publication.
Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. MAPH Enterprises LLC which owns www.MarijuanaStocks.com is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release.
MAPH Enterprises LLC, which owns www.MarijuanaStocks.com, may from time to time have a position in the securities mentioned herein and may increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice. MAPH Enterprises LLC, which owns www.MarijuanaStocks.com, may be compensated for its services in the form of cash-based compensation or equity securities in the companies it writes about, or a combination of the two. Pursuant to an agreement between an affiliate of MAPH Enterprises, LLC (owners of MarijuanaStocks.com), Midam Ventures LLC and Leafbuyer Technologies Inc., Midam is being paid $50,000 for a period of 30 days beginning November 1, 2018, and ending November 30, 2018. Midam has been paid an additional $50,000 and 40,000 common restricted shares of Leafbuyer Technologies, Inc. extending the contract another 30 days ending December 31, 2018. Midam has been compensated an additional $50,000 by Leafbuyer Technologies and has extended its period of coverage to January 31, 2019. We own 77,000 shares of Leafbuyer Technologies. We may buy or sell additional shares of (
View source version on accesswire.com: